The ERA-NET PrioMedChild (Priority Medicines for Children) is a network of eleven research funding organisations from different EU-member states working on the development of research around medicines for children. Under the umbrella of ERA-NET PrioMedChild, the national funding organisations of the Netherlands, Estonia, Finland, France, Great Britain, Italy, Latvia and Poland jointly provided funds in the order of €8 million to support the European call. The research projects were funded for three years in consortia with a minimum of three participants from at least three countries and a maximum number of 8 research groups. Regardless of its size, each collaborative consortium should have the optimal critical mass to achieve ambitious scientific goals and should clearly show the added value from working together. The ERA-NET PrioMedChild received €1.7 million from the European Commission's DG Research to set up the network and collaboration, but no funds for research. The Joint Call was funded out of national research budgets. Partnerships between research funding organisations seek to bring coherence and cooperation to national research programmes and policies on research on Priority Medicines for Children.
We are happy to announce that six projects submitted in the ERA-NET PRIOMEDCHILD Joint Call of 2010 received a grant.
The details of these projects are mentioned below, in random order. There are interviews available for all projects, please use the link provided in the title to open the interview.
1. "New drugs for rare diseases: cost-effectiveness modelling in cryopyrin associated periodic syndromes (CAPS)", coordinator: Prof. Dr. A..M. Martini, joined partnership of Italy, France, The Netherlands. Email the coordinator.
2. "Rare disease: use of clinical trial simulation for the choice and optimization of study design", coordinator: Dr. P.N. Nony, joined partnership of France, Italy, The Netherlands, United Kingdom. Email the coordinator.
3. "European Study of Neonatal Exposure to Excipients (ESNEE)", coordinator: Dr. M.A. Turner, joined partnership of United Kingdom, Estonia, France. Email the coordinator.
4."Validating non invasive imaging of the serotonergic- and dopaminergic system and adult neurogenesis with MRI; towards a better insight in the neurobiological mechanisms underlying psychiatric disorders in the paediatric population.", coordinator: Dr. L. Reneman, joined partnership of The Netherlands, France, Italy. Email the coordinator.
5. "Assessment of treatment effectiveness in childhood acute lymphoblastic leukaemia by monitoring minimal residual disease with 8-color flow cytometry", coordinator: Dr. T.S. Szczepanski, joined partnership of Poland, The Netherlands, Czech Republic. Email the coordinator.
6. "Paediatric Accelerator Mass Spectrometry Evaluation Research Study (PAMPERS)", coordinator: Prof. Dr. B.K. Park, joined partnership of United Kingdom, Estonia, Poland, The Netherlands. Email the coordinator.